Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

255

HTML

1787

Figures (1-4)

236

Sum=2278

Aug 7, 2007 (publication date) through Jan 10, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 7, 2007; 13(29): 4006-4010
Published online Aug 7, 2007. doi: 10.3748/wjg.v13.i29.4006

Full Size Figure Download Figure

Figure 2 Survival rate of cells transfected by AdKDR-tk or AdCMV-tk after GCV administration.

Citation: Li BJ, Zhang C, Yi YX, Hao Y, Liu XP, Ou QJ. Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene. World J Gastroenterol 2007; 13(29): 4006-4010
URL: https://www.wjgnet.com/1007-9327/full/v13/i29/4006.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i29.4006